Loading clinical trials...
Loading clinical trials...
Study of Humoral and Cellular Immunogenicity of Split-vaccine to Swine-origin H1N1 Influenza
Conditions
Interventions
split-virion, H1N1 vaccine of 15 μg
Locations
1
China
Institute of microbiology, Chinese Academy of Sciences
Beijing, Beijing Municipality, China
Start Date
March 1, 2010
Primary Completion Date
April 1, 2010
Completion Date
August 1, 2010
Last Updated
April 12, 2010
NCT04682444
NCT04431050
NCT02387294
NCT03448705
NCT03572491
NCT01651104
Lead Sponsor
Chinese Academy of Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions